MX2020009999A - Composiciones farmacéuticas para inhibir citocinas inflamatorias. - Google Patents
Composiciones farmacéuticas para inhibir citocinas inflamatorias.Info
- Publication number
- MX2020009999A MX2020009999A MX2020009999A MX2020009999A MX2020009999A MX 2020009999 A MX2020009999 A MX 2020009999A MX 2020009999 A MX2020009999 A MX 2020009999A MX 2020009999 A MX2020009999 A MX 2020009999A MX 2020009999 A MX2020009999 A MX 2020009999A
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical compositions
- inflammatory cytokines
- inhibiting inflammatory
- inhibiting
- cytokines
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Abstract
Composiciones farmaceuticas que comprenden tetrapeptidos específicos, para su uso para reducir la liberacion o inhibir la actividad de citocinas y mediadores inflamatorios y en el tratamiento de enfermedades y trastornos asociados con estas citocinas y mediadores.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862649940P | 2018-03-29 | 2018-03-29 | |
PCT/IL2019/050359 WO2019186561A1 (en) | 2018-03-29 | 2019-03-28 | Pharmaceutical compositions for inhibiting inflammatory cytokines |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2020009999A true MX2020009999A (es) | 2020-11-06 |
Family
ID=68058011
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2020009999A MX2020009999A (es) | 2018-03-29 | 2019-03-28 | Composiciones farmacéuticas para inhibir citocinas inflamatorias. |
Country Status (15)
Country | Link |
---|---|
US (2) | US11419913B2 (es) |
EP (1) | EP3773661A4 (es) |
JP (2) | JP7421219B2 (es) |
KR (1) | KR20200138326A (es) |
CN (1) | CN112203674A (es) |
AU (1) | AU2019245521A1 (es) |
BR (1) | BR112020019347A2 (es) |
CA (1) | CA3094295A1 (es) |
IL (1) | IL277436A (es) |
MX (1) | MX2020009999A (es) |
PH (1) | PH12020551573A1 (es) |
SG (1) | SG11202009257TA (es) |
UA (1) | UA126941C2 (es) |
WO (1) | WO2019186561A1 (es) |
ZA (1) | ZA202006412B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20220401336A1 (en) * | 2019-09-26 | 2022-12-22 | S.I.S. Shulov Innovative Science Ltd. | Anti-aging compositions and methods of use thereof |
WO2021059267A1 (en) * | 2019-09-26 | 2021-04-01 | S.I.S. Shulov Innovative Science Ltd. | Compositions and methods for treating degenerative, age-related and trauma-induced disorders |
US20230128280A1 (en) | 2020-10-23 | 2023-04-27 | Lg Energy Solution, Ltd. | Electrode Insulation Liquid Supply Apparatus and Electrode Insulation Liquid Supply Method |
WO2022254429A1 (en) * | 2021-05-31 | 2022-12-08 | S.I.S. Shulov Innovative Science Ltd. | Compositions and methods for treating respiratory distress |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1195762B (it) * | 1980-10-13 | 1988-10-27 | Reiner Alberto Real Sas | Derivati idrosolubili della cefalexina e procedimento per la loro produzione |
IT1172391B (it) | 1983-12-23 | 1987-06-18 | Polifarma Spa | Composti tirpeptidici contenenti acido piroglutaminico e triptofano,procedimentio di produzione ed applicazioni terapeutiche |
US6090790A (en) | 1989-12-14 | 2000-07-18 | Eriksson; Elof | Gene delivery by microneedle injection |
AR026801A1 (es) | 2000-01-12 | 2003-02-26 | Medidom Lab | Sustancias para uso en el tratamiento de la psoriasis |
IL137820A (en) * | 2000-08-10 | 2009-06-15 | S I S Shulov Inst For Science | Pharmaceutical composition for topical administration comprising an analgesic peptide |
EP2268279A1 (en) | 2008-03-24 | 2011-01-05 | Celgene Corporation | Treatment of psoriasis or psoriatic arthritis using cyclopropyl-n-{2-{(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl¨-3-oxoisoindoline-4-yl}carboxamide |
WO2010032322A1 (ja) | 2008-09-22 | 2010-03-25 | 日清ファルマ株式会社 | 抗炎症性ペプチド |
KR101290745B1 (ko) * | 2010-06-03 | 2013-07-29 | 한국해양과학기술원 | 라말린을 함유하는 염증질환 또는 면역질환의 예방 또는 치료용 약학 조성물 |
EP2691103B1 (en) * | 2011-03-28 | 2016-07-20 | S.I.S. Shulov Innovative Science Ltd. | Method for treating disorders of the skin |
WO2015197193A2 (en) * | 2014-06-26 | 2015-12-30 | Xigen Inflammation Ltd. | New use for jnk inhibitor molecules for treatment of various diseases |
CN103724204B (zh) | 2013-11-27 | 2016-05-11 | 北京化工大学 | 一种水溶性引发剂及制备 |
KR20170021349A (ko) * | 2014-06-26 | 2017-02-27 | 자이겐 인플라메이션 리미티드 | 다양한 질병의 치료를 위한 jnk 신호 전달 경로의 세포 투과성 펩타이드 억제자의 새로운 용도 |
-
2019
- 2019-03-28 CN CN201980031430.0A patent/CN112203674A/zh active Pending
- 2019-03-28 WO PCT/IL2019/050359 patent/WO2019186561A1/en active Application Filing
- 2019-03-28 BR BR112020019347-0A patent/BR112020019347A2/pt unknown
- 2019-03-28 CA CA3094295A patent/CA3094295A1/en active Pending
- 2019-03-28 UA UAA202006701A patent/UA126941C2/uk unknown
- 2019-03-28 EP EP19777428.4A patent/EP3773661A4/en active Pending
- 2019-03-28 SG SG11202009257TA patent/SG11202009257TA/en unknown
- 2019-03-28 AU AU2019245521A patent/AU2019245521A1/en active Pending
- 2019-03-28 JP JP2020552781A patent/JP7421219B2/ja active Active
- 2019-03-28 KR KR1020207031019A patent/KR20200138326A/ko not_active Application Discontinuation
- 2019-03-28 MX MX2020009999A patent/MX2020009999A/es unknown
- 2019-03-28 US US17/041,051 patent/US11419913B2/en active Active
-
2020
- 2020-09-17 IL IL277436A patent/IL277436A/en unknown
- 2020-09-28 PH PH12020551573A patent/PH12020551573A1/en unknown
- 2020-10-15 ZA ZA2020/06412A patent/ZA202006412B/en unknown
-
2022
- 2022-08-08 US US17/818,118 patent/US20220387547A1/en active Pending
-
2023
- 2023-11-29 JP JP2023201678A patent/JP2024015099A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CN112203674A (zh) | 2021-01-08 |
BR112020019347A2 (pt) | 2021-02-17 |
JP2021519773A (ja) | 2021-08-12 |
SG11202009257TA (en) | 2020-10-29 |
JP2024015099A (ja) | 2024-02-01 |
US11419913B2 (en) | 2022-08-23 |
RU2020134114A (ru) | 2022-04-29 |
EP3773661A1 (en) | 2021-02-17 |
WO2019186561A1 (en) | 2019-10-03 |
AU2019245521A1 (en) | 2020-11-12 |
CA3094295A1 (en) | 2019-10-03 |
UA126941C2 (uk) | 2023-02-22 |
US20210138023A1 (en) | 2021-05-13 |
ZA202006412B (en) | 2023-03-29 |
EP3773661A4 (en) | 2021-12-08 |
PH12020551573A1 (en) | 2021-09-13 |
JP7421219B2 (ja) | 2024-01-24 |
US20220387547A1 (en) | 2022-12-08 |
KR20200138326A (ko) | 2020-12-09 |
IL277436A (en) | 2020-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12019502058A1 (en) | Farnesoid x receptor agonists and uses thereof | |
PH12020551573A1 (en) | Pharmaceutical compositions for inhibiting inflammatory cytokines | |
PH12019501575A1 (en) | ISOFORM-SPECIFIC, CONTEXT-PERMISSIVE TGFá1 INHIBITORS AND USE THEREOF | |
PH12017501611A1 (en) | Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof | |
PH12018500586A1 (en) | Farnesoid x receptor agonists and uses thereof | |
MX2020012602A (es) | Composiciones bacterianas dise?adas y usos de las mismas. | |
PH12016501809A1 (en) | Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders | |
MX2017015574A (es) | Inhibidores de tirosina quinasa de bruton. | |
MX2021001186A (es) | Purinonas como inhibidores de proteasa especifica de ubiquitina 1. | |
MX2020009780A (es) | Compuestos de inhibidor de autotaxina. | |
MX2019015311A (es) | Composiciones de ésteres de ácido cannabidiólico y usos de las mismas. | |
TW201613919A (en) | Inhibitors of Bruton's tyrosine kinase | |
MX2022007436A (es) | Inhibidores de la autotaxina y sus usos. | |
PH12021550605A1 (en) | Farnesoid x receptor agonists and uses thereof | |
MX2022001061A (es) | Agentes de interleuquina-2 y usos de los mismos. | |
MX2022007994A (es) | Derivados de arilciclohexilamina y su uso en el tratamiento de trastornos psiquiátricos. | |
EP3583113A4 (en) | USE OF TGF-ALPHA FOR TREATMENT OF DISEASES AND DISORDERS | |
PH12017501980A1 (en) | The use of sgc stimulators, sgc activators, alone and combinations with pde5 inhibitors for the treatment of digital ulcers (du) concomitant to systemic sclerosis (ssc) | |
MX2023003678A (es) | Inhibidores de hidroxiesteroide 17beta- deshidrogenasa 13 (hsd17b13) y usos de estos. | |
MX2023003677A (es) | Inhibidores de hidroxiesteroide 17beta- deshidrogenasa 13 (hsd17b13) y usos de estos. | |
MX2023003675A (es) | Inhibidores de hidroxiesteroide 17beta-deshidrogenasa 13 (hsd17b13) y usos de estos. | |
AU2017258649A1 (en) | Covalent BTK inhibitors and uses thereof | |
WO2018033941A3 (en) | Pharmaceutical compositions of ibrutinib | |
WO2020109233A3 (en) | Trmt2a inhibitors for use in the treatment of polyglutamine diseases | |
MX2021007486A (es) | Hidrolizado de colageno para usarse con trastornos de la piel y trastornos intestinales. |